Obesity Management

Question 1

In patients who have concomitant obesity related disease, adjuvant pharmacotherapy is started at what BMI?

Answer 1

> = 27

If no comorbid, start at 30

Question 2

4 anti obesity meds approved by FDA

Answer 2

Lorcaserin
Phentermine/topiramate
Naltrexone/ bupropion
Liraglutide

Question 4

Most commonly prescribed anorexiant

Answer 4

Phentermine

Question 5

Anticonvulsant drug with a side effect of weights loss usually given with Phentermine

Answer 5

Topiramate

Question 6

Which of the ff is a selective 5-HT2 c receptor agonist
A. Orlistat
B. Lorcaserin
C. Naltrexone
D. Liraglutide

Answer 6

Lorcaserin

Question 7

Lorcaserin is said to decreased food intake via its actions where

Answer 7

Pro opiomelanocortin (POMC) system of neurons

Question 8

Mild reuptake inhibitor of dopamine and norepinephrine used in conjunction with Naltrexone for obesity

Answer 8

Bupropion

Question 9

Stimulates secretion of a melanocytes stimulating hormone (MSH) from POMC

Answer 9

Bupropion

Question 10

Blocks feedback inhibitory effects of opioid receptors activated by B endorphin released in the hypothalamus

Answer 10

Naltrexone

Question 11

Taken concomitantly with orlistat to control GI side effects

Answer 11

Psyllium mucilloid

Question 12

Vitamins that may be affected by Orlistat

Answer 12

Vitamin D
Vitamin E
Beta carotene

• fat soluble vitamins

Question 13

In patients who have concomitant obesity related disease, bariatric surgery is advised at what BMI?

Answer 13

> = 35

40 if no comorbids

Question 14

GLP 1 analogue used to treat obesity

Answer 14

Liraglutide

Question 15

Target weight loss for Obesity

Answer 15

6 months- 8-10 % wt loss